# QUETIAPINE FUMARATE
> **ANDA208781** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-04-26
## Drug
- **FDA Application Number:** ANDA208781
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** QUETIAPINE FUMARATE
- **Generic name:** QUETIAPINE
- **Active ingredients:** QUETIAPINE FUMARATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **Manufacturer:** Solco Healthcare U.S., LLC
- **First approval:** 2022-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208781)
---
*MORVS · CC0 1.0*